Circio

Develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.

Launch date

2010

Employees

Market cap

Enterprise valuation

($13m) (Public information from Sep 2024)

Company register number 996162095

Oslo Norway (HQ)

https://www.circio.com/

https://twitter.com/targovax https://www.linkedin.com/company/targovax-as

Authorizing premium user...